Charles Zhu
Stock Analyst at LifeSci Capital
(3.23)
# 1,059
Out of 4,734 analysts
24
Total ratings
47.62%
Success rate
16.77%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Charles Zhu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RPTX Repare Therapeutics | Downgrades: Market Perform | n/a | $1.24 | - | 1 | Dec 13, 2024 | |
| TNGX Tango Therapeutics | Maintains: Buy | $18 → $8 | $3.08 | +159.74% | 3 | Nov 7, 2024 | |
| MGNX MacroGenics | Upgrades: Buy | $12 | $3.00 | +300.00% | 4 | Nov 7, 2023 | |
| MRUS Merus | Maintains: Buy | $46 → $48 | $39.74 | +20.79% | 6 | Aug 8, 2023 | |
| NUVL Nuvalent | Initiates: Buy | $56 | $78.28 | -28.46% | 1 | Jul 24, 2023 | |
| TARA Protara Therapeutics | Assumes: Buy | $22 | $4.76 | +362.18% | 1 | Jul 10, 2023 | |
| COGT Cogent Biosciences | Reiterates: Buy | $26 | $8.20 | +217.07% | 3 | Jun 13, 2023 | |
| IDYA IDEAYA Biosciences | Reiterates: Buy | $32 | $23.15 | +38.23% | 3 | Mar 8, 2023 | |
| ZYME Zymeworks | Upgrades: Buy | $14 | $14.29 | -2.03% | 2 | May 5, 2022 |
Repare Therapeutics
Dec 13, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $1.24
Upside: -
Tango Therapeutics
Nov 7, 2024
Maintains: Buy
Price Target: $18 → $8
Current: $3.08
Upside: +159.74%
MacroGenics
Nov 7, 2023
Upgrades: Buy
Price Target: $12
Current: $3.00
Upside: +300.00%
Merus
Aug 8, 2023
Maintains: Buy
Price Target: $46 → $48
Current: $39.74
Upside: +20.79%
Nuvalent
Jul 24, 2023
Initiates: Buy
Price Target: $56
Current: $78.28
Upside: -28.46%
Protara Therapeutics
Jul 10, 2023
Assumes: Buy
Price Target: $22
Current: $4.76
Upside: +362.18%
Cogent Biosciences
Jun 13, 2023
Reiterates: Buy
Price Target: $26
Current: $8.20
Upside: +217.07%
IDEAYA Biosciences
Mar 8, 2023
Reiterates: Buy
Price Target: $32
Current: $23.15
Upside: +38.23%
Zymeworks
May 5, 2022
Upgrades: Buy
Price Target: $14
Current: $14.29
Upside: -2.03%